Free Trial

Smart for Life (SMFL) Competitors

Smart for Life logo
$0.0037 +0.00 (+37.04%)
As of 10/17/2025 01:25 PM Eastern

SMFL vs. VRPX, SCPS, VAXX, TRVN, ARDS, NAVB, GNCAQ, GNCA, STAB, and EVLO

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), Vaxxinity (VAXX), Trevena (TRVN), Aridis Pharmaceuticals (ARDS), Navidea Biopharmaceuticals (NAVB), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Statera Biopharma (STAB), and Evelo Biosciences (EVLO). These companies are all part of the "pharmaceutical products" industry.

Smart for Life vs. Its Competitors

Smart for Life (NASDAQ:SMFL) and Virpax Pharmaceuticals (NASDAQ:VRPX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

28.4% of Smart for Life shares are held by institutional investors. Comparatively, 32.2% of Virpax Pharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by company insiders. Comparatively, 3.7% of Virpax Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Virpax Pharmaceuticals has lower revenue, but higher earnings than Smart for Life.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smart for Life$11.11M0.00-$22.68MN/AN/A
Virpax PharmaceuticalsN/AN/A-$15.19MN/AN/A

Smart for Life's return on equity of 0.00% beat Virpax Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Smart for LifeN/A N/A N/A
Virpax Pharmaceuticals N/A -1,554.34%-338.29%

In the previous week, Smart for Life's average media sentiment score of 0.00 equaled Virpax Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Smart for Life Neutral
Virpax Pharmaceuticals Neutral

Smart for Life has a beta of 16.69, suggesting that its stock price is 1,569% more volatile than the S&P 500. Comparatively, Virpax Pharmaceuticals has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500.

Summary

Smart for Life beats Virpax Pharmaceuticals on 5 of the 7 factors compared between the two stocks.

Get Smart for Life News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$26K$3.88B$6.14B$10.56B
Dividend YieldN/AN/A5.72%4.83%
P/E RatioN/A10.0385.7027.05
Price / Sales0.0078.10612.92132.35
Price / CashN/A7.2425.8230.35
Price / Book0.001.4312.226.58
Net Income-$22.68M$19.57M$3.33B$276.84M
7 Day PerformanceN/A-13.54%1.17%1.93%
1 Month PerformanceN/A-5.52%6.85%2.19%
1 Year PerformanceN/A-4.55%58.93%34.62%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMFL
Smart for Life
N/A$0.00
+37.0%
N/A-87.7%$26K$11.11M0.00110Gap Down
VRPX
Virpax Pharmaceuticals
0.2135 of 5 stars
$0.01
-47.6%
N/A-99.9%$14KN/A0.007
SCPS
Scopus BioPharma
N/A$0.00
-70.0%
N/AN/A$13KN/A0.009
VAXX
Vaxxinity
N/A$0.00
flat
N/A-50.0%$13KN/A0.0090Gap Up
TRVN
Trevena
1.4481 of 5 stars
$0.01
flat
$5.00
+41,566.7%
-99.4%$12K$443K0.0040
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/AN/A$11KN/A0.0030Gap Down
NAVB
Navidea Biopharmaceuticals
N/AN/AN/AN/A$10K$8.13K0.0010High Trading Volume
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
STAB
Statera Biopharma
N/A$0.00
flat
N/AN/A$5KN/A0.0020High Trading Volume
EVLO
Evelo Biosciences
N/A$0.00
flat
N/A-33.3%$4KN/A0.00120News Coverage
Options Volume

Related Companies and Tools


This page (NASDAQ:SMFL) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners